Scalpel Weekly News

Week of: June 19, 2017

IN THE NEWS


Opana ER Removed from Market by FDA; Opioid Pain Drug Abuse

On June 8, 2017, the FDA requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. Click title to continue reading...


 
MEDICAL ALERTS


Dermal Fillers; Risks of Cosmetic Injectables

On June 8, 2017, the FDA updated its information on dermal fillers, also known as injectable implants, soft tissue fillers, or wrinkle fillers. Dermal fillers are medical device implants approved by the FDA for use in helping to create a smoother and/or fuller appearance in the face, including nasolabial folds, cheeks and lips, and for increasing the volume of the back of the hand. Click title to continue reading...



High-Dose Influenza Vaccine Best for Preventing Deaths

On June 9, 2017, the FDA announced that high-dose influenza vaccine was more effective at preventing post-influenza deaths among elderly individuals during the 2012-2013 influenza season than standard-dose vaccines—when the A(H3N2) influenza viruses were broadly circulating, according to the results of a joint study done by researchers at the FDA, CDC, and the Centers for Medicare and Medicaid Services. Click title to continue reading...



Patients in Health Care Facilities at Risk for Legionnaires’ Disease

On June 6, 2017, the CDC published the report of a study that found that people got Legionnaires’ disease from a health care facility in 76% of locations reporting exposures. This is a concerning finding because Legionnaires’ disease acquired from health care facilities can be particularly severe. Click title to continue reading...


  CASE ALERTS


Florida Court Rejects Caps on Med Mal Noneconomic Damages

A woman underwent outpatient carpal tunnel surgery. During intubation, as part of the administration of anesthesia for the surgery, one of the tubes perforated the woman’s esophagus. Click title to continue reading...



Expert Causation Testimony Required; Hospital Failed to Prevent Transfer

A 36-year-old woman, pregnant with a third child and midway through the third trimester, was taken by ambulance to the hospital’s labor and delivery emergency room. The woman had been vomiting and was experiencing fever, abdominal pain, and mild contractions. Click title to continue reading...



Hospital’s Contracts with Health Care Insurers Did Not Foreclose Competition

The largest hospital serving a three county area entered contracts with health insurance plans that use restricted-provider networks, meaning that each plan has a network of hospitals and other health-care providers that have agreed to charge the plan’s members specified rates. Click title to continue reading...


FEATURE


Checklist: Asthma Treatment Malpractice Client Interview

As a special feature for our Premium subscribers we have included this feature containing an illustrative checklist for litigation involving injury sustained as the result of asthma treatment malpractice. In this illustrative case, a patient went to a physician complaining of respiratory problems. Click title to continue reading...